- Home
- BRTX vs APCX Comparison
BRTX vs APCX Comparison
Compare BRTX & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- APCX
- Stock Information
- Founded
- BRTX 1997
- APCX 2006
- Country
- BRTX United States
- APCX United States
- Employees
- BRTX N/A
- APCX N/A
- Industry
- BRTX Managed Health Care
- APCX Finance: Consumer Services
- Sector
- BRTX Health Care
- APCX Finance
- Exchange
- BRTX Nasdaq
- APCX Nasdaq
- Market Cap
- BRTX 10.7M
- APCX 12.6M
- IPO Year
- BRTX N/A
- APCX N/A
- Fundamental
- Price
- BRTX $1.58
- APCX $0.37
- Analyst Decision
- BRTX Strong Buy
- APCX
- Analyst Count
- BRTX 1
- APCX 0
- Target Price
- BRTX $18.00
- APCX N/A
- AVG Volume (30 Days)
- BRTX 1.1M
- APCX 264.9K
- Earning Date
- BRTX 03-28-2025
- APCX 03-31-2025
- Dividend Yield
- BRTX N/A
- APCX N/A
- EPS Growth
- BRTX N/A
- APCX N/A
- EPS
- BRTX N/A
- APCX N/A
- Revenue
- BRTX $377,000.00
- APCX $365,000.00
- Revenue This Year
- BRTX $482.76
- APCX $1,315.48
- Revenue Next Year
- BRTX $212.24
- APCX N/A
- P/E Ratio
- BRTX N/A
- APCX N/A
- Revenue Growth
- BRTX 189.55
- APCX N/A
- 52 Week Low
- BRTX $1.03
- APCX $0.31
- 52 Week High
- BRTX $2.55
- APCX $1.70
- Technical
- Relative Strength Index (RSI)
- BRTX 41.43
- APCX 42.77
- Support Level
- BRTX $1.46
- APCX $0.38
- Resistance Level
- BRTX $1.68
- APCX $0.43
- Average True Range (ATR)
- BRTX 0.22
- APCX 0.04
- MACD
- BRTX -0.01
- APCX -0.00
- Stochastic Oscillator
- BRTX 25.81
- APCX 13.12
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payments and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.